Skip to main content

Table 3 Insurer payment to hospital during primary hospitalization: matched comparisons between patients with healthcare acquired infection and their controls

From: Is it financially beneficial for hospitals to prevent nosocomial infections?

  Cases Controls Difference p-value
USD
  Mean Mean (min, max)c Mean (min, max)c Mean (min, max)c
CLABSIa 24,673 10,065 (3281,24,673) 14,608 (0,21,392) < 0.001 (< 0.001, 0.18)
CDIa 11,468 6038 (2795,9895) 5430 (1573,8673) 0.02 (< 0.001, 0.53)
SSI b 9819 9793 (9749,9792) 26 (−40, 70) 0.77 (0.54, 0.54)
  1. a Hospitalization-days × cost per day
  2. b Diagnosis-related group (DRG)
  3. c min, mean of matched control patients with minimum resource consumption; max, mean of matched control patients with maximum resource consumption
  4. USD US Dollar, CLABSI central-line associated bloodstream infection, CDI Clostridium difficile infection, SSI surgical site infection